Tagged with Patient centricity

Patient-Centricity and Product Quality: A Global Leadership Opportunity

Global Patient-Centricity and Product Quality: A Global Leadership Opportunity

Global Sarah Pope Miksinski, executive director/CMS regulatory affairs, and Gregory Rullo, senior director regulatory affairs, at AstraZeneca discuss the need for common ground among regulators and industry when it comes to patient centricity and for strategic leadership to address differing regulatory control-strategy requirements. In today’s increasingly complex and intricate pharmaceutical landscape,…

Interview: Philippe Hügli – Country Coordinator, Boston Scientific Switzerland

Switzerland Interview: Philippe Hügli – Country Coordinator, Boston Scientific Switzerland

Switzerland Working to stay ahead in the highly competitive medical device field, Boston Scientific’s Philippe Hügli launched a Customer Insight Initiative in Switzerland which has served as a pilot for the European organization. Considering the immense competition in the medical device industry today, what do you see as the key trends…

Interview: Dr. Andrea Michael Meyer – General Manager, Sanofi Genzyme Switzerland

Switzerland Interview: Dr. Andrea Michael Meyer – General Manager, Sanofi Genzyme Switzerland

Switzerland Dr. Andrea Michael Meyer, general manager of Sanofi Genzyme Switzerland, reveals how the Swiss business has been experiencing year-on-year double-digit growth; how rare diseases was the foundation of Sanofi Genzyme´s business and remains a key part of their DNA; and how a focus on patient centricity remains at the core…

Interview: Elie Lobel – CEO, Orange Healthcare, France

Healthcare Interview: Elie Lobel – CEO, Orange Healthcare, France

Healthcare Orange Healthcare CEO Elie Lobel discusses the importance of digitalization to the healthcare industry, major challenges, and the tremendous work that has already been done in the e-health regulatory field both in France and internationally. Could you give us a brief introduction to Orange Healthcare? What are the milestones and achievements…

Interview: Pamela Alexa – Country Manager, Pfizer Switzerland

Pharma Interview: Pamela Alexa – Country Manager, Pfizer Switzerland

Pharma Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active rheumatoid arthritis, building upon Pfizer’s tradition of developing patient-centered therapies. She also discusses supporting research in Switzerland through the Pfizer Research Prize Foundation, which celebrates its 25th anniversary in 2016. What have…

Interview: Renata Martinakova – Country Manager, LEO Pharma Czech Republic & Slovakia

Pharma Interview: Renata Martinakova – Country Manager, LEO Pharma Czech Republic & Slovakia

Pharma The country manager of LEO Pharma Czech Republic and Slovakia explains how the recent acquisition of Astella’s dermatology portfolio will triple the revenue of the affiliate and how LEO always puts patients first Could you please introduce yourself and the cornerstones of your longstanding career in the pharmaceutical industry? The…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page